Almanac A1C

Cortisol Chaos – Tame Your Stress Hormone to Save Your Metabolism

Posted

by

dr. Karunia Valeriani Japar

Table of Contents
Keywords: , , , ,

The Modern Epidemic of Stress

Over the past several decades, chronic psychological stress has emerged as a defining feature of modern living continuous connectivity, high work demands, social pressures, and environmental uncertainty have resulted in a persistent activation of the human stress response. Unlike acute stress, which serves an adaptive role in enhancing alertness and survival, chronic stress exerts a sustained physiological burden that disrupts homeostasis across multiple organ systems. Epidemiological data now link psychosocial stress to a wide spectrum of non-communicable diseases, underscoring its role as a silent driver of metabolic and cardiovascular dysfunction in the 21st century.

At the center of the body’s stress response lies cortisol, the primary glucocorticoid hormone produced by the adrenal cortex under the regulation of the hypothalamic-pituitary-adrenal (HPA) axis. Cortisol follows a robust circadian rhythm, peaking in the early morning hours to promote wakefulness and energy mobilization, and declining throughout the day to allow nocturnal recovery. Under chronic psychological or physical stress, this rhythm becomes dysregulated, resulting in prolonged cortisol elevation or, conversely, hypocortisolemia due to HPA axis fatigue. Both patterns with adverse metabolic outcomes and impaired resilience.

The regulation of cortisol is therefore central not only to stress adaptation but also to long-term cardiometabolic health. Sustained cortisol excess contributes to central adiposity, insulin resistance, hypertension, and systemic inflammation, each of which increase the risk of metabolic syndrome and atherosclerotic disease. Elevated cortisol also disrupts sleep-wake cycles, impairs thyroid and gonadal function, and accelerates biological aging via oxidative and mitochondrial stress. Understanding how to restore physiological cortisol rhythms offers a promising avenue to improve metabolic balance, emotional stability, and longevity in an increasingly stressful world.

Cortisol Physiology: Understanding the Stress Hormone

Cortisol is the main glucocorticoid produced by the zona fasciculata of the adrenal cortex and is released under the control of the hypothalamic-pituitary-adrenal (HPA) axis. In response to stress exposure, corticotropin-releasing hormone from the hypothalamus stimulates adrenocorticotropic hormone release from the anterior pituitary, which in turn drives cortisol secretion from the adrenal glands. Cortisol exerts negative feedback at the level of the hypothalamus, pituitary, and higher brain centers, maintaining homeostatic control of the stress response under physiological conditions [1,2,3].

A defining feature of cortisol biology is its circadian and ultradian rhythmicity. The central pacemaker in the suprachiasmatic nucleus of the hypothalamus generates a 24-hour rhythm in HPA activity, leading to a pronounced early-morning peak in cortisol and a nadir around midnight. Superimposed on this circadian pattern are pulsatile secretory bursts occurring multiple times per day, which allow a dynamic, graded response to environmental and internal stimuli. Sleep architecture and wake timing further modulate this rhythm, with slow-wave sleep suppressing HPA activity and sleep deprivation or nocturnal awakening triggering additional cortisol release [1,4,5].

From a functional perspective, cortisol is essential for energy mobilization and short‑term survival during acute stress. It increases gluconeogenesis, promotes insulin resistance, and enhances lipolysis, ensuring adequate glucose and substrate availability for the brain and working muscles during threat states. In the cardiovascular system, cortisol supports blood pressure maintenance and vascular reactivity, contributing to the classic “fight‑or‑flight” phenotype. However, when stressors are frequent or prolonged, persistent HPA activation leads to allostatic load, characterized by chronically elevated cortisol and progressive dysregulation of its receptor signalling [3,6,7,8].

Clinically, the distinction between adaptive acute stress responses and maladaptive chronic activation is crucial. Acute spikes in cortisol are typically transient and tightly coupled to specific challenges, whereas chronic psychological or metabolic stress can blunt diurnal variation, flatten the morning peak, or paradoxically induce periods of relative hypocortisolism after prolonged overactivation. These altered patterns are strongly associated with central adiposity, insulin resistance, and low‑grade inflammation, anchoring cortisol physiology at the core of stress‑related cardiometabolic disease [6,9,10].

The Metabolic Cost of Chronic Stress

Chronic psychological stress imposes a substantial metabolic burden through sustained activation of the hypothalamic-pituitary-adrenal (HPA) axis and resultant dysregulation of cortisol secretion. Under normal physiological conditions, cortisol follows a robust circadian rhythm, peaking in the early morning and declining throughout the day to permit nocturnal recovery. However, chronic stress flattens this diurnal slope, blunts the morning peak, and elevates evening cortisol concentrations, creating a state of prolonged glucocorticoid exposure that disrupts metabolic homeostasis. The neuroendocrine pathways linking chronic cortisol elevation to metabolic dysregulation involve both central and peripheral mechanisms. At the central level, persistent stress impairs negative feedback sensitivity of the HPA axis, reducing glucocorticoid receptor (GR) expression in the hippocampus and hypothalamus, which perpetuates corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) release. Peripherally, chronic cortisol excess drives insulin resistance through multiple convergent pathways, including impaired insulin-dependent glucose transporter 4 (GLUT4) translocation in skeletal muscle and adipose tissue, enhanced hepatic gluconeogenesis via upregulation of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), and direct inhibition of insulin secretion from pancreatic β-cells through disruption of calcium signalling and glucose sensing. These mechanisms collectively promote hyperglycemia, compensatory hyperinsulinemia, and eventual β-cell exhaustion, establishing a direct link between chronic stress and type 2 diabetes risk [7,9,11,12].

Figure 1. Glucocorticoid promote whole-body insulin resistance via visceral adipogenesis, mobilization and release of free fatty acids into the circulation, and development of hepatic steatosis [9]

The influence of chronic cortisol elevation on lipid metabolism is particularly evident in the pattern of visceral adipose tissue accumulation and dyslipidemia characteristic of metabolic syndrome. Cortisol promotes adipogenesis by stimulating the differentiation of preadipocytes into mature adipocytes, preferentially in visceral depots where 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity converts inactive cortisone to active cortisol. This tissue-specific amplification of glucocorticoid signalling inhibits adenosine monophosphate-activated protein kinase (AMPK) activity, shifting adipose tissue metabolism toward lipogenesis and fat storage while simultaneously increasing lipolysis and circulating free fatty acids. The resulting elevation in systemic free fatty acids further exacerbates insulin resistance in muscle and liver, creating a self-perpetuating cycle of metabolic dysfunction. Clinical studies demonstrate that individuals with chronic stress exhibit increased urinary excretion of cortisol metabolites, elevated fasting triglycerides, reduced high-density lipoprotein cholesterol, and greater visceral adiposity, independent of body mass index. These lipid abnormalities are mechanistically linked to cortisol-induced hepatic steatosis and impaired clearance of atherogenic lipoproteins, accelerating cardiovascular disease progression [7,9,12,13].

Thyroid function represents another critical target of chronic cortisol dysregulation, with stress-induced hypercortisolemia impairing both central and peripheral thyroid hormone metabolism. At the hypothalamic-pituitary level, elevated cortisol suppresses thyrotropin-releasing hormone (TRH) secretion and blunts pituitary responsiveness, leading to reduced thyrotropin (TSH) release and altered thyroid-stimulating hormone dynamics. Cortisol also inhibits the peripheral conversion of thyroxine (T4) to the biologically active triiodothyronine (T3) by suppressing 5′-deiodinase activity, while promoting conversion to the inactive reverse T3 (rT3). This results in a state of functional hypothyroidism characterized by reduced metabolic rate, fatigue, and weight gain, despite often-normal circulating TSH levels. The bidirectional relationship between the HPA and hypothalamic-pituitary-thyroid (HPT) axes creates a vicious cycle: hypothyroidism itself increases cortisol secretion as the body attempts to compensate for reduced metabolic activity, further exacerbating HPA axis dysfunction and metabolic impairment [6,7].

The inflammatory cascade initiated by chronic stress represents a fundamental mechanism linking cortisol dysregulation to metabolic disease. Pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β), are chronically elevated in individuals with chronic stress and visceral obesity. These cytokines directly activate the HPA axis by stimulating CRH and ACTH release, while simultaneously increasing 11β-HSD1 expression in adipose tissue, thereby amplifying local cortisol production. The resulting hypercortisolemia further promotes adipocyte dysfunction and sustained cytokine release, establishing a feed-forward loop of inflammation and metabolic dysregulation. Elevated IL-6 concentrations correlate strongly with visceral adiposity and insulin resistance, while TNF-α impairs insulin signalling through serine phosphorylation of insulin receptor substrate-1 (IRS-1) and promotes lipolysis. This chronic low-grade inflammation, measurable through elevated high-sensitivity C-reactive protein (hsCRP) and cytokine profiles, represents a key pathophysiological bridge between psychological stress and cardiometabolic disease [7,14].

Assessment of cortisol status and its metabolic impact relies on several validated biomarkers that capture different aspects of HPA axis function. Fasting morning serum cortisol provides a snapshot of basal HPA activity but lacks temporal resolution. Salivary cortisol testing offers non-invasive measurement of free, biologically active hormone and is particularly useful for evaluating the cortisol awakening response (CAR) and diurnal slope. The morning cortisol slope, calculated from samples collected upon waking and 30-60 minutes later, reflects HPA axis reactivity and is blunted in chronic stress and metabolic syndrome. Heart rate variability (HRV), particularly the high-frequency component, serves as an indirect marker of parasympathetic tone and HPA axis balance, with reduced HRV indicating sympathetic dominance and chronic stress load. Integration of these biomarkers with metabolic parameters which are fasting glucose, insulin, HOMA-IR, lipid panels, and inflammatory markers that provides a comprehensive framework for evaluating the metabolic cost of chronic stress and monitoring therapeutic interventions aimed at restoring HPA axis homeostasis [5,7].

Evidence-Based Interventions to Lower Cortisol

Lifestyle and Behavioral Strategies

Regular physical exercise represents a potent modulator of HPA axis activity, though its effects on cortisol are highly dependent on intensity, duration, and timing. Moderate-intensity aerobic exercise performed for 30–45 minutes at 50–60% VO₂max typically reduces baseline cortisol levels over time and enhances recovery from stress-induced spikes, whereas high-intensity interval training (HIIT) or prolonged vigorous exercise (>75% VO₂max) acutely elevates cortisol to support energy mobilization. Critically, this acute exercise-induced cortisol rise is transient and resolves within 60–90 minutes post-exercise in well-trained individuals, often followed by a rebound suppression of nocturnal cortisol that may persist for 24–48 hours. However, when training volume exceeds recovery capacity, manifesting as overtraining syndrome, cortisol levels become chronically elevated, diurnal rhythm flattens, and performance declines by >10%. To optimize cortisol regulation, clinicians should recommend consistent moderate aerobic activity (e.g., brisk walking, cycling) 3–5 times weekly, limit HIIT to 1–2 sessions per week with adequate recovery, and incorporate resistance training 2–3 times weekly, as combined aerobic and resistance programs have demonstrated superior reductions in resting cortisol compared to either modality alone [15,16,17,18].

Circadian alignment through strategic sleep hygiene and light exposure offers a foundational approach to normalizing cortisol rhythms. The cortisol awakening response (CAR), a 50-100% surge  in cortisol within 30–60 minutes of waking serves as a key marker of HPA axis health and is blunted in chronic stress and depression. Exposure to natural sunlight within the first 1–2 hours of waking, even on cloudy days, robustly stimulates the suprachiasmatic nucleus, reinforcing the central circadian pacemaker and amplifying the CAR while ensuring appropriate evening cortisol decline. Conversely, evening exposure to bright light suppresses melatonin and disrupts the nocturnal cortisol nadir, contributing to metabolic dysregulation. Maintaining consistent sleep-wake times with 7–9 hours of sleep opportunity preserves the cortisol diurnal slope; sleep deprivation or irregular schedules flatten this rhythm and elevate evening cortisol, independent of stressors. Clinical recommendations should emphasize morning outdoor light exposure for 10–15 minutes, evening dim-light environments, and regular sleep schedules as non-pharmacologic HPA axis stabilizers [5,19,20].

Mindfulness-based stress reduction (MBSR) and yoga-based interventions demonstrate consistent efficacy in reducing cortisol secretion, with effect sizes most pronounced in individuals with elevated baseline stress. Meta-analytical evidence indicates that MBSR programs reduce salivary cortisol by 15–25%, with greater reductions observed in protocols exceeding 20 total hours of practice and in participants with high pre-intersection cortisol reactivity. Focused-attention meditation specifically attenuates the cortisol response to acute psychosocial stressors, whereas open-monitoring practices enhance recovery from stress-induced spikes. Yoga asanas combined with pranayama (breathing exercises) produce comparable cortisol reductions; a meta-analysis of 42 randomized controlled trials reported significant decreases in salivary cortisol, systolic blood pressure, and inflammatory cytokines following yoga interventions. Heated hatha yoga shows particular promise in high cortisol reactors, reducing stress-reactivity by 40–50% after 8-week programs. Slow breathing techniques (4–6 breaths/minute) activate parasympathetic pathways, increase heart rate variability, and directly lower cortisol within 20-minute sessions. These modalities appear to co-regulate the HPA axis through enhanced prefrontal cortex regulation of limbic stress circuits and improved vagal tone, offering accessible, low-cost interventions for chronic stress management [21,22,23,24,25,26].

Nutritional and Supplement Strategies

Stabilizing blood glucose through strategic macronutrient composition represents a foundational nutritional approach to cortisol regulation. The cortisol awakening response is intimately linked to overnight glycemic stability; nocturnal hypoglycemia triggers compensatory cortisol release to mobilize hepatic glucose stores, thereby disrupting the natural morning cortisol peak. Protein-rich meals attenuate postprandial glycemic excursions by slowing gastric emptying and modulating incretin hormone secretion, which reduces the demand for cortisol-mediated gluconeogenesis. A meta-analysis of 14 randomized trials demonstrated that low-glycemic index diets reduced glycated proteins by 7.4% compared to high-glycemic diets, with concomitant improvements in fasting cortisol slopes. Conversely, refined carbohydrates provoke rapid insulin spikes followed by reactive hypoglycemia, activating the HPA axis and elevating cortisol by 15–25% within 90 minutes post-ingestion. Clinical recommendations emphasize consuming 25–30 g of high-quality protein at breakfast to anchor the cortisol awakening response, distributing protein evenly across meals (0.25–0.4 g/kg body weight per meal), and limiting refined carbohydrate intake to <10% of total calories to prevent cortisol-mediated glycemic rescue [27,28].

Adaptogenic herbs modulate HPA axis activity through multimodal mechanisms, with ashwagandha (Withania somnifera) emonstrating the most robust evidence for cortisol reduction. A 2023 systematic review of nine clinical trials reported that ashwagandha supplementation (300–600 mg/day standardized to 5% withanolides) reduced serum cortisol by 11–32.6% over 30–112 days, with greater effects observed in chronically stressed populations. The withanolides appear to regulate cortisol via glucocorticoid receptor sensitization and CRH suppression, while also enhancing GABAergic tone to reduce anxiety symptoms. Rhodiola (Rhodiola rosea) exhibits biphasic, dose-dependent effects characteristic of adaptogens: at low doses (200–400 mg/day), it reduces cortisol reactivity to acute stress by 15–20% while preserving performance, whereas higher doses can blunt the physiological stress response excessively. A randomized trial found that rhodiola extract prevented the 200–300% cortisol increase typically seen during immobilization stress in animal models, maintaining cortisol at basal levels through modulation of stress-activated protein kinases. Holy basil ( Ocimum sanctum) contains eugenol and ursolic acid that modulate HPA axis activity; a double-blind, placebo-controlled study reported significant reductions in generalized anxiety disorder symptoms and salivary cortisol after 8 weeks of holy basil supplementation (300 mg twice daily). These adaptogens appear to exert their effects by normalizing the sensitivity of glucocorticoid receptors in the hippocampus and prefrontal cortex, thereby restoring appropriate negative feedback inhibition of the HPA axis [29,30,31,32,33,34].

Omega-3 fatty acids, magnesium, and phosphatidylserine function as critical cofactors in HPA axis regulation and cortisol metabolism. Omega-3 supplementation (1.25–2.5 g/day EPA+DHA) reduces total cortisol release during stress exposure by 19% in a dose-dependent manner, while also attenuating IL-6 and preserving telomerase activity, suggesting anti-aging effects beyond cortisol modulation. The mechanism involves incorporation of omega-3s into neuronal membranes, which reduces pro-inflammatory cytokine production and enhances glucocorticoid receptor sensitivity. Magnesium deficiency potentiates HPA axis hyperactivity; intracerebroventricular administration of low-magnesium solutions increases cortisol secretion by 30–40% in animal models, while magnesium supplementation (300–500 mg/day) reduces ACTH release and adrenocortical sensitivity to ACTH. Magnesium acts as a natural calcium channel blocker and GABA agonist, directly inhibiting CRH release from the hypothalamus during stress. Phosphatidylserine, a phospholipid component of neuronal membranes, demonstrates acute cortisol-lowering effects when administered at 400–800 mg/day, particularly in individuals with elevated baseline cortisol. Studies show phosphatidylserine reduces exercise-induced cortisol by 20–30% and may alleviate anxiety and mood disturbances associated with hypercortisolemia by protecting neuronal membranes from glucocorticoid-induced damage. These adjunctive nutrients should be considered in integrative protocols targeting HPA axis dysregulation, with dosing individualized based on baseline cortisol, inflammatory markers, and dietary intake [35,36,37,38,39].

Psychophysiological Modulation

Heart rate variability (HRV) training through biofeedback represents a direct method for enhancing vagal tone and recalibrating HPA axis responsiveness. Vagal nerve activity, indexed by high-frequency HRV, exerts inhibitory control over hypothalamic CRH release and modulates adrenal cortisol secretion through direct neural pathways. A prospective study of 171 healthy adults demonstrated that individuals exhibiting larger HRV decreases during stress anticipation showed proportionally greater cortisol reactivity, while those maintaining higher vagal tone displayed blunted HPA responses. HRV biofeedback training, typically involving slow-paced breathing at 0.1 Hz (6 breaths/minute) for 20–30 minutes daily over 8–12 weeks, increases root mean square of successive differences (RMSSD) by 25–40% and reduces salivary cortisol awakening response by 15–20%. The mechanism involves strengthening of prefrontal cortex regulation over limbic stress circuits and enhancement of baroreflex sensitivity, which improves parasympathetic control of both cardiac and adrenal function. Notably, the anticipatory HRV response predicts 38.9% of variance in stress-induced cortisol increase, suggesting that training vagal tone during stress anticipation may be more effective than attempting modulation during active stress. Clinical applications should emphasize HRV biofeedback as a preventive tool, with regular practice reducing allostatic load and improving metabolic resilience in chronically stressed population [40,41,42,43,44].

Thermal stress therapies, including cold exposure and sauna bathing, induce hormetic adaptations that recalibrate the HPA axis and reduce cortisol reactivity over time. Cold water immersion (8–12°C) initially triggers sympathetic activation and norepinephrine release, but paradoxically does not significantly elevate cortisol during acute exposure; instead, cortisol levels decrease by 47% at 180 minutes post-immersion, indicating enhanced recovery and reduced allostatic load. Repeated cold exposure over 4 weeks produces habituation, with cortisol responses diminishing while norepinephrine elevation persists, suggesting selective adaptation of the HPA axis relative to the sympathetic nervous system. This differential adaptation may enhance stress resilience, as reduced cortisol reactivity to cold correlates with improved psychological stress management in daily life. Conversely, sauna bathing (70–90°C) acutely decreases serum cortisol by 29% during 72-minute sessions, with greater reductions observed in individuals with higher baseline cortisol levels. The heat shock protein (HSP) response to repeated sauna use appears to protect glucocorticoid receptors from downregulation, preserving HPA axis sensitivity while reducing overall cortisol output. Regular sauna users show attenuated cortisol responses to subsequent stressors, indicating that controlled thermal stress can recalibrate the neuroendocrine stress response. Clinical protocols should incorporate 15–20 minutes of cold exposure 2–3 times weekly or 30–45 minutes of sauna bathing 3–4 times weekly to optimize HPA axis adaptation, with careful monitoring in individuals with cardiovascular compromise [45,46,47].

Digital detox and nature exposure represent emerging interventions for neuroendocrine rebalancing by reducing psychosocial stressors and enhancing physiological recovery. Social media engagement and screen time correlate positively with perceived stress and cortisol elevation, likely through mechanisms of social comparison, attentional fatigue, and disrupted sleep architecture. A digital detox intervention of 7 days reduced salivary cortisol by 12% and improved subjective well-being, with effects mediated by reduced exposure to curated social comparisons and restoration of natural circadian rhythms. Complementing this, nature exposure (“green time”) produces dose-dependent reductions in cortisol, with 20–30 minutes in natural environments eliciting a 21.3% per hour decline beyond normal diurnal variation. The cortisol response to nature is most efficient between 21–30 minutes, after which benefits continue but at a reduced rate. Urban green space access is associated with steeper diurnal cortisol slopes and lower perceived stress, particularly in women, suggesting gender-specific neuroendocrine benefits. The mechanisms involve reduced sensory load, enhanced parasympathetic activation, and improved affective regulation, with nature exposure increasing high-frequency HRV by 15–20% during and after the experience. Integrative recommendations should prescribe 20–30 minutes of daily nature exposure combined with structured digital detox periods (e.g., 1 day weekly or 7 days quarterly) to optimize HPA axis recovery and reduce allostatic load in chronically stressed individuals [49,50].

Integrative Clinical Framework

An effective integrative model for cortisol management combines behavioral, nutritional, and biofeedback interventions within a structured, personalized protocol that addresses the multifactorial nature of HPA axis dysregulation. The BERN framework (Behavior, Exercise, Relaxation, Nutrition) provides a useful organizing principle, emphasizing that sustainable cortisol reduction requires simultaneous modification of lifestyle domains rather than isolated interventions. Clinicians should initiate treatment with a comprehensive assessment phase lasting 2–4 weeks, during which baseline cortisol patterns, glycemic variability, autonomic tone, and psychological stress load are quantified using objective monitoring tools. This data-driven approach allows identification of individual stress triggers and metabolic vulnerabilities, enabling precise tailoring of intervention intensity and sequencing. For example, patients exhibiting flattened cortisol awakening responses with high glycemic variability may prioritize protein-rich breakfasts and morning light exposure, while those with blunted HRV and elevated evening cortisol may benefit more from HRV biofeedback and digital detox protocols. The model progresses through three phases: (1) stabilization (weeks 1–4), focusing on sleep regularization, glycemic control, and basic stress management techniques; (2) optimization (weeks 5–12), introducing adaptogens, thermal therapies, and structured exercise programs based on initial response; and (3) maintenance (ongoing), emphasizing habit consolidation and periodic reassessment. This phased approach prevents overwhelming patients while building self-efficacy through measurable improvements in biomarkers [51].

Continuous glucose monitoring (CGM) has emerged as a powerful tool for tracking the metabolic manifestations of stress in non-diabetic individuals, revealing how psychological stress elevates glucose through cortisol-mediated hepatic gluconeogenesis. In healthy adults, acute psychosocial stress increases glucose by 5–15 mg/dL within 30–60 minutes, with the magnitude correlating strongly with salivary cortisol rise. CGM data demonstrate that individuals with chronic stress exhibit greater glycemic variability, more frequent excursions >140 mg/dL, and delayed return to baseline, patterns that predict future insulin resistance independent of fasting glucose. A case series of 15 executives using CGM during high-stress work periods revealed that perceived stress scores correlated with postprandial glucose spikes (r=0.62, p<0.01), particularly following carbohydrate-rich meals consumed during stressful meetings. The real-time feedback from CGM enables patients to identify stress-eating patterns and modify meal timing and composition to minimize cortisol-glycemic interactions. For clinical application, CGM should be prescribed for 2–4 weeks during initial assessment and periodically during high-stress periods, with interpretation focusing on glycemic variability metrics (coefficient of variation <36% is optimal) rather than absolute glucose values. Integration of CGM data with cortisol and HRV measurements provides a comprehensive view of the stress-metabolism axis, allowing clinicians to demonstrate to patients how stress management interventions directly improve metabolic stability [52,53,54].

Wearable HRV monitors and psychological stress assessments complement CGM by capturing autonomic and perceptual dimensions of stress that glucose alone cannot reflect. Modern wearable devices (e.g., Garmin, Oura, Apple Watch) provide continuous HRV tracking through photoplethysmography, with root mean square of successive differences (RMSSD) serving as a reliable proxy for parasympathetic tone. In a study of 657 participants, wearable-derived HRV correlated with perceived stress in laboratory settings (r=0.45), though the association weakened in real-world contexts, highlighting the need for multimodal assessment. Clinical validation studies demonstrate that wearable HRV monitors can detect stress episodes with 70–80% accuracy when combined with accelerometry and sleep data, making them valuable for longitudinal tracking of treatment response. The Perceived Stress Scale (PSS-10) and the Copenhagen Psychosocial Questionnaire (COPSOQ) provide validated subjective complements to physiological data, assessing cognitive appraisal and psychosocial stressors that drive HPA activation. For example, a 45-year-old female executive presenting with burnout exhibited PSS-10 scores of 28 (high stress), RMSSD of 18 ms (low vagal tone), and frequent nocturnal glucose elevations to 150 mg/dL. Following a 12-week integrative protocol combining HRV biofeedback, ashwagandha supplementation (300 mg twice daily), and morning sunlight exposure, her PSS-10 decreased to 14, RMSSD increased to 42 ms, and nocturnal glucose variability reduced by 40%. This case illustrates how combining wearable HRV, CGM, and psychological assessments enables personalized treatment tracking and demonstrates tangible improvements across physiological and subjective domains [55,56,57,58,59].

A 38-year-old male software engineer presented with central adiposity, poor sleep quality, and irritability, reporting high work demands and constant connectivity. Baseline assessment revealed a flattened cortisol awakening response (CAR increase of only 15% vs. expected 50%), HRV RMSSD of 22 ms, and CGM showing average glycemic variability of 42 mg/dL with frequent post-dinner spikes to 160 mg/dL. The integrative protocol implemented behavioural strategies first: digital detox from 8 PM to 8 AM, morning sunlight exposure within 30 minutes of waking, and 20 minutes of slow-paced breathing (6 breaths/minute) before bed. Nutritional interventions included a protein-rich breakfast (30 g), elimination of refined carbohydrates at dinner, and ashwagandha supplementation (600 mg standardized extract). After 8 weeks, his CAR normalized to a 55% increase, RMSSD improved to 38 ms, and glycemic variability decreased to 28 mg/dL, with subjective stress ratings dropping from 8/10 to 4/10. This vignette demonstrates the clinical utility of objective monitoring in guiding intervention sequencing and motivating adherence by providing visible biomarker improvements that correlate with symptom resolution.

Future Directions

Emerging evidence highlights the gut microbiota as a critical regulator of HPA axis function, suggesting that microbiome-targeted therapies may become central to cortisol modulation strategies. Stress-induced activation of the HPA axis alters gut microbial composition and increases intestinal permeability, permitting translocation of lipopolysaccharides that amplify systemic inflammation and further stimulate cortisol secretion, thereby establishing a feed-forward loop between dysbiosis and HPA dysregulation. Conversely, experimental modulation of the gut microbiota through probiotics, prebiotics, or fecal microbiota transplantation normalizes corticosterone rhythms and reduces stress-related behavioural phenotypes in animal models, supporting the concept of a gut–microbiota–HPA axis triad as a therapeutic target for stress-related metabolic and mood disorders. However, human data remain preliminary, with small sample sizes and heterogeneous methodologies, underscoring the need for large, longitudinal trials that link specific microbial signatures to cortisol phenotypes and clinical outcomes [60,61,62,63,64].

Chrononutrition, focusing on the timing, frequency, and distribution of food intake relative to circadian rhythms has emerged as another promising frontier for cortisol and metabolic regulation. Irregular feeding patterns, late-night eating, and breakfast skipping are associated with delayed glucose rhythms, phase shifts in core body temperature, and blunted cortisol secretion, all of which contribute to circadian misalignment and metabolic risk. In pregnant women, breakfast skipping is linked to lower awakening cortisol yet greater cortisol amplitude later in the day, indicating that meal timing can reshape diurnal cortisol dynamics independent of total caloric intake. Experimental data suggest that restricting the eating window to earlier daytime hours improves insulin sensitivity, reduces evening cortisol, and restores alignment between central and peripheral clocks, but optimal timing windows and inter-individual variability remain poorly defined. Future research should integrate CGM, salivary cortisol profiling, and actigraphy to dissect how specific chrononutrition patterns modulate the stress–metabolism interface across different populations and disease states [65,66,67].

Precision digital interventions and AI-driven stress profiling represent a rapidly evolving domain with the potential to transform individualized cortisol management. Wearable devices now capture multimodal biosignals, including HRV, electrodermal activity, accelerometry, and sometimes sweat contrisol in near real time, enabling continuous inference of stress states beyond traditional clinic-based assessments. A recent scoping review of personalized stress detection models found that multimodal approaches integrating photoplethysmography, electrodermal activity, and accelerometry outperform single-signal models, achieving substantially higher accuracy in distinguishing mental from physical stress. Next-generation platforms are beginning to combine interstitial glucose data from CGM with HRV and sleep metrics to model the dynamic coupling between stress, cortisol, and glycemic variability. Prototype smartwatches integrating HRV with sweat cortisol sensors illustrate a future in which real-time cortisol estimation could trigger just-in-time interventions such as as guided breathing, micro-breaks, or adaptive nutrition prompts, delivered via mobile applications [65,66,67].

Despite these advances, major research gaps persist in translating AI-driven stress profiling into clinically actionable, equitable tools. Current models frequently rely on small, homogeneous datasets and lack external validation, limiting generalizability across ages, ethnicities, and occupational contexts. Moreover, most algorithms optimize for stress detection accuracy rather than clinical endpoints such as improved metabolic control, reduced cortisol variability, or lower incidence of cardiometabolic disease. There is a pressing need for prospective, randomized trials where AI systems not only detect stress but dynamically adjust integrated intervention bundles, combining behavioural, nutritional and biofeedback components and are evaluated on hard outcomes such as HOMA-IR, visceral adiposity, and diurnal cortisol slope. Ethical frameworks addressing data privacy, algorithmic bias, and user autonomy will be essential to ensure that precision stress-medicine augments, rather than fragments, the therapeutic alliance between clinicians and patients [68,69,70,71,72].

Restoring Balance for Long-Term Health

Reducing pathological cortisol exposure emerges from this article as a central strategy for preserving metabolic resilience and extending healthspan. By restoring a physiological diurnal rhythm through sleep and circadian alignment, glycemic stabilization, targeted movement, adaptogenic and nutritional support, and psychopshysiological practices, clinicians can interrupt the feed-forward loops linking chronic stress to insulin resistance, visceral adiposity, low-grade inflammation, and neuroendocrine dysfunction, thereby lowering the long-term risk of cardiometabolic disease, frailty and premature aging. Interventions that normalized HPA axis function not only improve glucose and lipid homeostasis but also enhance sleep quality, cognitive and emotional regulation, and overall quality of life, positioning cortisol modulation as a unifying target in preventive and longevity medicine.

Translating this evidence into real-world impact requires a proactive integrative approach that embeds behavioral, nutritional, and biofeedback strategies into both clinical care and pathway and everyday routines. Clinicians are uniquely positioned to lead this shift by combining continuous monitoring tools (e.g., salivary cortisol, CGM, HRV wearables) with personalized protocols and structured follow-up, while individuals are called to actively engage in reshaping their environments, habits, and digital exposures to support healthy stress physiology. Framed this way, “cortisol care” becomes a shared ongoing process, linking medical practice, technology, and daily self-management to restore balance and build durable resilience in an increasingly stressful world.

Reference

  1. Buckley TM, Schatzberg AF. On the Interactions of the Hypothalamic-Pituitary-Adrenal (HPA) Axis and Sleep: Normal HPA Axis Activity and Circadian Rhythm, Exemplary Sleep Disorders. The Journal of Clinical Endocrinology & Metabolism [Internet]. 2005 May;90(5):3106–14. Available from: https://academic.oup.com/jcem/article/90/5/3106/2837129
  2. Thau L, Gandhi J, Sharma S. Physiology, Cortisol [Internet]. National Library of Medicine. StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538239/
  3. Kördel M, Meier M, Kühnel A, Kroemer NB. Metabolic state shapes cortisol reactivity to acute stress: A systematic review and meta-analysis of metabolic and hormonal modulators. Neurobiology of Stress. 2025 Nov;39:100764.
  4. Androulakis IP. Circadian rhythms and the HPA axis: A systems view. WIREs Mechanisms of Disease. 2021 Jan 12;13(4).
  5. O’Byrne NA, Yuen F, Butt WZ, Liu PY. Sleep and circadian regulation of cortisol: A short review. Current Opinion in Endocrine and Metabolic Research [Internet]. 2021 Jun 1;18(18):178–86. Available from: https://www.sciencedirect.com/science/article/pii/S2451965021000363?via%3Dihub
  6. Knezevic E, Nenic K, Milanovic V, Knezevic NN. The role of cortisol in chronic stress, neurodegenerative diseases, and psychological disorders. Cells [Internet]. 2023 Nov 29;12(23):2726–6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10706127/
  7. Sic A, Cvetkovic K, Manchanda E, Knezevic NN. Neurobiological Implications of Chronic Stress and Metabolic Dysregulation in Inflammatory Bowel Diseases. Diseases. 2024 Sep 18;12(9):220–0.
  8. Jones B. Impact of Stress Hormones on Metabolic Syndrome Development and Management. Endocrinology & Metabolic Syndrome [Internet]. 2024 Dec 25;13(4):1–2. Available from: https://www.longdom.org/open-access/impact-of-stress-hormones-on-metabolic-syndrome-development-and-management-1101932.html?utm_source=chatgpt.com
  9. Geer EB, Islam J, Buettner C. Mechanisms of Glucocorticoid-Induced Insulin Resistance. Endocrinology and Metabolism Clinics of North America [Internet]. 2014 Mar;43(1):75–102. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942672/
  10. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis. The Journal of Clinical Endocrinology & Metabolism. 2009 Aug 1;94(8):2692–701.
  11. O’Byrne NA, Yuen F, Butt WZ, Liu PY. Sleep and circadian regulation of cortisol: A short review. Current Opinion in Endocrine and Metabolic Research [Internet]. 2021 Jun 1;18(18):178–86. Available from: https://www.sciencedirect.com/science/article/pii/S2451965021000363?via%3Dihub
  12. Paredes S, Ribeiro L. Cortisol: the villain in Metabolic Syndrome? Revista da Associação Médica Brasileira [Internet]. 2014 Feb;60(1):84–92. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302014000100084
  13. Boscaro M, Giacchetti G, Ronconi V. Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations. Annals of the New York Academy of Sciences. 2012 Jul 17;1264(1):87–102.
  14. Chan KL, Cathomas F, Russo SJ. Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder. Physiology. 2019 Mar 1;34(2):123–33.
  15. HACKNEY AC, WALZ EA. Hormonal adaptation and the stress of exercise training: the role of glucocorticoids. Trends in sport sciences [Internet]. 2018 Jun 5;20(4):165. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5988244/
  16. Caplin A, Chen FS, Beauchamp MR, Puterman E. The Effects of Exercise Intensity on the Cortisol Response to a Subsequent Acute Psychosocial Stressor. Psychoneuroendocrinology [Internet]. 2021 Sep;131(1):105336. Available from: https://www.sciencedirect.com/science/article/pii/S0306453021002109
  17. How Exercise Balances Cortisol Levels [Internet]. Lifestyle Medicine. 2025. Available from: https://lifestylemedicine.stanford.edu/how-exercise-balances-cortisol-levels/
  18. Overtraining Syndrome [Internet]. Physiopedia. Available from: https://www.physio-pedia.com/Overtraining_Syndrome
  19. Jung CM, Khalsa SBS, Scheer FAJL, Cajochen C, Lockley SW, Czeisler CA, et al. Acute Effects of Bright Light Exposure on Cortisol Levels. Journal of Biological Rhythms [Internet]. 2010 May 19;25(3):208–16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686562/
  20. Oak Park Clinic. Optimising Your Sleep Through Strategic Daylight Exposure [Internet]. Oak Park Clinic. 2024. Available from: https://www.oakparkclinic.co.uk/optimising-your-sleep-through-strategic-daylight-exposure
  21. Avant Interventional Psychiatry East Cobb [Internet]. Avantpsychiatry.com. 2025 [cited 2025 Dec 29]. Available from: https://www.avantpsychiatry.com/breathing-techniques-in-yoga-for-anxiety-and-stress-management
  22. Örün D, Karaca S, Arıkan Ş. The Effect of Breathing Exercise on Stress Hormones. Cyprus Journal of Medical Sciences. 2021 Dec 31;6(1):22–7.
  23. Ooishi Y, Fujino M, Inoue V, Nomura M, Kitagawa N. Differential Effects of Focused Attention and Open Monitoring Meditation on Autonomic Cardiac Modulation and Cortisol Secretion. Frontiers in Physiology. 2021 Jul 15;12.
  24. Sanada K, Montero-Marin J, Alda Díez M, Salas-Valero M, Pérez-Yus MC, Morillo H, et al. Effects of Mindfulness-Based Interventions on Salivary Cortisol in Healthy Adults: A Meta-Analytical Review. Frontiers in Physiology. 2016 Oct 19;7.
  25. Pascoe MC, Thompson DR, Ski CF. Yoga, mindfulness-based stress reduction and stress-related physiological measures: A meta-analysis. Psychoneuroendocrinology [Internet]. 2017 Dec;86(86):152–68. Available from: https://www.sciencedirect.com/science/article/pii/S0306453017300409
  26. Hopkins LB, Medina JL, Baird SO, Rosenfield D, Powers MB, Smits JAJ. Heated hatha yoga to target cortisol reactivity to stress and affective eating in women at risk for obesity-related illnesses: A randomized controlled trial. Journal of Consulting and Clinical Psychology. 2016 Jun;84(6):558–64.
  27. Chiu CJ, Taylor A. DIETARY HYPERGLYCEMIA, GLYCEMIC INDEX AND METABOLIC RETINAL DISEASES. Progress in retinal and eye research [Internet]. 2011 Jan 1;30(1):18–53. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005015/
  28. High-Protein Breakfast Swaps to Stabilize Your Blood Sugar Levels All Day – Beauty [Internet]. Oregonstate.edu. 2025 [cited 2025 Dec 29]. Available from: https://blogs.oregonstate.edu/beauty/2025/11/24/high-protein-breakfast-swaps-to-stabilize-your-blood-sugar-levels-all-day/
  29. Ashwagandha (Withania somnifera) [Internet]. Restorative Medicine. Available from: https://restorativemedicine.org/library/monographs/ashwagandha/
  30. Panossian A, Hambardzumyan M, Hovhanissyan A, Wikman G. The Adaptogens Rhodiola and Schizandra Modify the Response to Immobilization Stress in Rabbits by Suppressing the Increase of Phosphorylated Stress-activated Protein Kinase, Nitric Oxide and Cortisol. Drug Target Insights. 2007 Jan;2:117739280700200.
  31. Agapouda A, Grimm A, Lejri I, Eckert A. Rhodiola Rosea Extract Counteracts Stress in an Adaptogenic Response Curve Manner via Elimination of ROS and Induction of Neurite Outgrowth. Chen L, editor. Oxidative Medicine and Cellular Longevity. 2022 May 13;2022:1–19.
  32. Sprengel M, Laskowski R, Jost Z. Withania somnifera (Ashwagandha) supplementation: a review of its mechanisms, health benefits, and role in sports performance. Nutrition & metabolism [Internet]. 2025 May;22(1):9. Available from: https://pubmed.ncbi.nlm.nih.gov/39910586/
  33. Harnessing the Power of Holy Basil: Nature’s Answer to Cortisol and Stress [Internet]. Evergreen Institute. 2024 [cited 2025 Dec 29]. Available from: https://www.theevergreeninstitute.org/post/harnessing-the-power-of-holy-basil-nature-s-answer-to-cortisol-and-stress
  34. Explore Remarkable Holy Basil Cortisol Effects for Adrenal Health [Internet]. Lam Clinic. 2016. Available from: https://lamclinic.com/blog/holy-basil-cortisol-benefits-for-adrenal-fatigue/
  35. Madison AA, Belury MA, Andridge R, Renna ME, Rosie Shrout M, Malarkey WB, et al. Omega-3 supplementation and stress reactivity of cellular aging biomarkers: an ancillary substudy of a randomized, controlled trial in midlife adults. Molecular Psychiatry. 2021 Apr 20;26(7):3034–42.
  36. Cuciureanu MD, Vink R. Magnesium and stress [Internet]. Nih.gov. University of Adelaide Press; 2011. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507250/
  37. Tuttle D. Cortisol [Internet]. Lifeextension.com. Life Extension; 2025 [cited 2025 Dec 29]. Available from: https://www.lifeextension.com/magazine/2004/7/report_cortisol
  38. Tsolmon Tsogbayar, MD. How do magnesium supplements for high cortisol work? [Internet]. SiPhox Health. 2025 [cited 2025 Dec 29]. Available from: https://siphoxhealth.com/articles/how-do-magnesium-supplements-for-high-cortisol-work
  39. Phosphatidylserine: The New Cortisol Modulator Or Not? [Internet]. Lam Clinic. 2021 [cited 2025 Dec 29]. Available from: https://lamclinic.com/blog/phosphatidylserine-elevated-cortisol-levels/
  40. Pulopulos MM, Vanderhasselt MA, De Raedt R. Association between changes in heart rate variability during the anticipation of a stressful situation and the stress-induced cortisol response. Psychoneuroendocrinology. 2018 Aug;94:63–71.
  41. Kula Y, Horosov R, Gidron Y, Ekshtein A, Gordon B, Iversen Z, et al. Pre-training heart rate variability as a predictor of Air Force Academy completion. da Costa JAHC, editor. PLOS One [Internet]. 2025 Aug 7 [cited 2025 Nov 17];20(8):e0327406. Available from: https://proxy.lirn.net/MuseProxyID=mp01/MuseSessionID=001pgwx/MuseProtocol=https/MuseHost=pubmed.ncbi.nlm.nih.gov/MusePath/40773446/
  42. Van Dijk W, Huizink AC, Müller J, Uvnäs-Moberg K, Ekström-Bergström A, Handlin L. The Effect of Mechanical Massage and Mental Training on Heart Rate Variability and Cortisol in Swedish Employees—A Randomized Explorative Pilot Study. Frontiers in Public Health. 2020 Mar 19;8.
  43. Gitler A, Yosef YB, Kotzer U, Levine A. Harnessing non‑invasive vagal neuromodulation: HRV biofeedback and SSP for cardiovascular and autonomic regulation (Review). Medicine International [Internet]. 2025 Apr 29;5(4):1–13. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12082064/
  44. Ahokas EK, Kyröläinen H, Ihalainen JK, Hanstock HG. Salivary cortisol response to post-exercise infrared sauna declines over time. Temperature. 2025 Apr 27;1–15.
  45. Podstawski R, Borysławski K, Pomianowski A, Krystkiewicz W, Żurek P. Endocrine Effects of Repeated Hot Thermal Stress and Cold Water Immersion in Young Adult Men. American Journal of Men’s Health. 2021 Mar;15(2):155798832110083.
  46. Psychiatry & Psychotherapy Podcast [Internet]. Psychiatry & Psychotherapy Podcast. 2019 [cited 2025 Dec 29]. Available from: https://www.psychiatrypodcast.com/cohort
  47. Jumping into the Ice Bath Trend! Mental Health Benefits of Cold Water Immersion [Internet]. Lifestyle Medicine. 2024. Available from: https://lifestylemedicine.stanford.edu/jumping-into-the-ice-bath-trend-mental-health-benefits-of-cold-water-immersion/
  48. Roe J, Thompson C, Aspinall P, Brewer M, Duff E, Miller D, et al. Green Space and Stress: Evidence from Cortisol Measures in Deprived Urban Communities. International Journal of Environmental Research and Public Health [Internet]. 2013 Sep 2;10(9):4086–103. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799530/
  49. Ramadhan RN, Rampengan DD, Yumnanisha DA, Tjandra KC, Ariyanto MV. Impacts of digital social media detox for mental health: A systematic review and meta-analysis. Narra J [Internet]. 2024 Aug 7;4(2):e786–6. Available from: https://www.narraj.org/main/article/view/786
  50. Hunter MCR, Gillespie BW, Chen SYP. Urban Nature Experiences Reduce Stress in the Context of Daily Life Based on Salivary Biomarkers. Frontiers in Psychology [Internet]. 2019 Apr 4;10(1). Available from: https://www.frontiersin.org/articles/10.3389/fpsyg.2019.00722/full
  51. Esch T, Stefano GB. The BERN Framework of Mind-Body Medicine: Integrating Self-Care, Health Promotion, Resilience, and Applied Neuroscience. Frontiers in Integrative Neuroscience. 2022 Jul 14;16.
  52. Continuous Glucose Monitoring for Non Diabetics: A New Frontier in Metabolic Health Optimization – Vasculearn Network (VLN) [Internet]. Thrombosis.org. 2025. Available from: https://thrombosis.org/patients/patient-articles/continuous-glucose-monitoring-for-non-diabetics-a-new-frontier-in-metabolic-health-optimization
  53. Attia P. Continuous glucose monitoring to improve health in non-diabetics [Internet]. Peter Attia. 2023. Available from: https://peterattiamd.com/cgm-in-non-diabetics/
  54. Kinny F, Läer S, Obarcanin E, Kinny F, Läer S, Obarcanin E. Continuous Glucose Monitoring under standardised conditions regarding diet, exercise and stress in Healthy Young People (CGM-HYPE study): An exploratory clinical trial. PLOS Digital Health [Internet]. 2025 Nov 14;4(11):e0001087–7. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12617953/
  55. Gerwin JN, Gustavo, Boyce MW, Joseph M, Wong AH, Burleson W, et al. HRVEST: a novel data solution for using wearable smart technology to measure physiologic stress variables during a randomized clinical trial. Frontiers in Computer Science. 2024 Feb 22;6.
  56. Frisone F, Sicari F, Settineri S, Merlo EM. Clinical Psychological Assessment of Stress: A Narrative Review of the Last 5 Years. Clinical Neuropsychiatry [Internet]. 2021;18(2):91–100. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629067/
  57. None Vijay Girdhar, Bhatt NS. Integrative management of generalized anxiety disorder: A case study on subconscious energy healing therapy with emotional freedom techniques. World Journal of Advanced Research and Reviews. 2025 Jan 10;25(1):461–7.
  58. D Brisinda, Florio ED, C Savorgnan, A Affanni, M Minen, D Minen, et al. Clinical validation of a novel wearable system for real-time telemetric transmission of transient changes of cardiac autonomic modulation induced by psychophysiological and physical stress. European Heart Journal [Internet]. 2020 Nov 1 [cited 2025 Dec 29];41(Supplement_2). Available from: https://academic.oup.com/eurheartj/article/41/Supplement_2/ehaa946.3476/6002385?login=false
  59. Li K, Cardoso C, Moctezuma-Ramirez A, Abdelmotagaly Elgalad, Perin EC. Heart Rate Variability Measurement through a Smart Wearable Device: Another Breakthrough for Personal Health Monitoring? International Journal of Environmental Research and Public Health. 2023 Dec 6;20(24):7146–6.
  60. Rusch JA, Layden BT, Dugas LR. Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Frontiers in Endocrinology [Internet]. 2023 Jun 19;14. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10316519/
  61. A preliminary study of gut microbiome variation and HPA axis reactivity in healthy infants. Psychoneuroendocrinology [Internet]. 2021 Feb 1;124:105046. Available from: https://www.sciencedirect.com/science/article/pii/S0306453020304698?via%3Dihub
  62. Bertollo AG, Santos CF, Bagatini MD, Ignácio ZM. Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression. Frontiers in Neuroscience. 2025 Feb 6;19.
  63. Marwaha K, Cain R, Asmis K, Czaplinski K, Holland N, Mayer DCG, et al. Exploring the Complex Relationship Between Psychosocial Stress and the Gut Microbiome: Implications for Inflammation and Immune Modulation. Journal of Applied Physiology. 2025 Jan 15;138(2).
  64. Vagnerová K, Vodička M, Hermanová P, Ergang P, Šrůtková D, Klusoňová P, et al. Interactions Between Gut Microbiota and Acute Restraint Stress in Peripheral Structures of the Hypothalamic–Pituitary–Adrenal Axis and the Intestine of Male Mice. Frontiers in Immunology. 2019 Nov 19;10.
  65. Teoh AN, Kaur S, Shafie SR, Mohd Shukri NH, Ahmad Bustami N, Takahashi M, et al. Chrononutrition is associated with melatonin and cortisol rhythm during pregnancy: Findings from MY-CARE cohort study. Frontiers in Nutrition. 2023 Jan 6;9.
  66. Johnston JD, Ordovás JM, Scheer FA, Turek FW. Circadian Rhythms, Metabolism, and Chrononutrition in Rodents and Humans. Advances in Nutrition [Internet]. 2016 Mar 1;7(2):399–406. Available from: https://academic.oup.com/advances/article/7/2/399/4558098#110039540
  67. Pooja Toshniwal Paharia. News-Medical [Internet]. News-Medical. 2025 [cited 2025 Dec 29]. Available from: https://www.news-medical.net/health/Chrononutrition-Explained-Why-When-You-Eat-Matters-for-Metabolic-Health.aspx
  68. Fraser RA, Walker RJ, Campbell JA, Ekwunife O, Egede LE. Integration of artificial intelligence and wearable technology in the management of diabetes and prediabetes. npj Digital Medicine [Internet]. 2025 Nov 18;8(1). Available from: https://www.nature.com/articles/s41746-025-02036-9
  69. Bolpagni M, Pardini S, Dianti M, Gabrielli S. Personalized Stress Detection Using Biosignals from Wearables: A Scoping Review. Sensors [Internet]. 2024 May 18;24(10):3221–1. Available from: https://www.mdpi.com/1424-8220/24/10/3221
  70. Blaha Y, Cavelti M, Sele S, Koenig J, Zimmermann R, Schmeck K, et al. Beyond Self-Reports: Integrating Cortisol Measurement in Psychotherapy Process Research among Adolescents with Borderline Personality Pathology. Psychotherapy and Psychosomatics [Internet]. 2025 Aug 24 [cited 2025 Dec 29];1–13. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12503824/
  71. Epstein CM, Houfek JF, Rice MJ, Weiss SJ. Integrative Review of Early Life Adversity and Cortisol Regulation in Pregnancy. Journal of Obstetric, Gynecologic & Neonatal Nursing. 2021 May;50(3):242–55.
  72. Smith SW, Johnson PR, Sullivan WE, Mauzy CR, Arroyo Antúnez BE, Craig AR, et al. Cortisol as a Biomarker for Stress During the Assessment and Treatment of Destructive Behavior. Behavioral Sciences [Internet]. 2025 Apr 6 [cited 2025 Dec 29];15(4):475. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12024409/

‌